Table 3.
Trial | Treatment | n | Dilatation at ‘active phase’ onset (cm)a |
Median duration (hrs) |
Rate of ‘active phase’ dilation (cm/hr)b |
---|---|---|---|---|---|
Fraser et al, 1993 22 | Routine early amniotomy | 390 | 3.8 (0.9) | 4.33 | 1.4 |
Conservative membrane management | 383 | 3.8 (0.8) | 6.42 | 1.0 | |
Dickinson et al, 1997 18 | Epidural analgesia group | 257 | 4c | 4.6 | 1.3 |
Non-epidural group | 240 | 4c | 2.75 | 2.2 | |
Sadler et al, 2000 32 | AML group (vaginal delivery) | 290 | 4.5 (1.8) | 4.0 | 1.4 |
Routine management (vaginal delivery) | 299 | 4.5 (2.1) | 4.83 | 1.1 | |
Zhang et al, 2001 34 | Before ‘on-demand’ epidural analgesia | 507 | 4 | 6.0 | 1.0 |
After ‘on-demand’ epidural analgesia | 581 | 4 | 6.0 | 1.0 | |
Vahratian et al, 2005 38 | Spontaneous onset of labor group | 1171 | 4 | 5.97 | 1.0 |
Mikki et al, 2007 39 | Early amniotomy | 74 | 3 [3,4] | 3.5 | 2.0 |
Intent to conserve membranes | 83 | 4 [3,4] | 5.0 | 1.2 | |
Miquelutti et al, 2007 20 | Upright position group | 35 | 4c | 6.5 | 0.9 |
Control group | 42 | 4c | 5.42 | 1.1 | |
Svärdby et al, 2007 21 | No augmentation | 50 | 4c | 5.08 | 1.2 |
Active phase augmentation | 88 | 4c | 7.32 | 0.8 | |
Second stage augmentation | 26 | 4c | 7.33 | 0.8 | |
Weighted values | 4516 |
4.0 (0.2) |
5.4 (1.0) |
1.2 (0.3) |
AML = active management of labor
Group mean (SD), median [IQR], or absolute value shown when provided in study.
Calculated based on assumption that the cervical dilation phase ends at 10 cm which approximates complete cervical dilatation.
Through contact with author, it was clarified that ‘active phase’ onset was defined as 4 cm dilatation.